BETA: Please send your feedback!
Vifor Pharma
VIFN-CH:SWX
Pharmaceuticals: Major
—
MID cap
(—)
—
since start of 2021
—
About
Pharmaceuticals: Major
Founded 1927
Vifor Pharma AG, formerly Galenica AG, is a global specialty pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. The company was founded in 1927 and is headquartered in Bern, Switzerland.
website
Headquarters
Executives
| Name | Title | Gender |
| Etienne Jornod | Executive Chairman | Male |
| Felix Burkhard | Chief Financial Officer & Head-Retail Business | Male |
| Oliver P. Kronenberg, PhD | Head-Corporate Legal | Male |
| Julien Vignot | Head-Investor Relations | Male |
Mindful Investing Summary
Vifor Pharma - Competitors and Related Companies
How Vifor Pharma stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
Vifor Pharma
VIFN-CH:SWX
Pharmaceuticals: Major
—
MID cap
(—)
—
since start of 2021
—
Bachem
BANB-CH:SWX
Pharmaceuticals: Major
—
SMALL cap
(—)
—
since start of 2021
—
Basilea Pharmaceutica
BSLN-CH:SWX
Pharmaceuticals: Major
—
SMALL cap
(—)
—
since start of 2021
—
Addex Therapeutics
ADXN-CH:SWX
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
Evolva
EVE-CH:SWX
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—